Consistent data in life sciences: the key to reliable, reproducible, and actionable research
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
Turning claims into interoperable evidence More means more. In a world where anyone can make claims, only taXonomy Pathways makes claims interoperable. That’s the difference between simply collecting data and creating evidence that is complete,...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
The evolution of heart failure treatment and research Heart failure remains one of the most prevalent and costly chronic diseases in the United States, affecting more than 6.7 million adults and projected to reach 8.7 million by 2030.1 It is the lead...